Trial Profile
A phase II study of remimazolam in general anesthesia
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 07 Dec 2018
Price :
$35
*
At a glance
- Drugs Remimazolam (Primary)
- Indications General anaesthesia
- Focus Therapeutic Use
- 07 Dec 2018 New trial record